Combined chelation therapy improves glucose metabolism in patients with β-thalassaemia major [6]

British Journal of Haematology

Volumn 135, Issue 2, 2006, Pages 271-272

  Christoforidis, Athanasios ^a   Perifanis, Vassilios ^a   Athanassiou Metaxa, Miranda ^a  

^a Aristotle University Medical School   (Greece)

Author keywords

thalassaemia; Combined therapy; Deferiprone; Deferoxamine; Glucose metabolism

Indexed keywords

DEFERIPRONE; DEFEROXAMINE;

ADULT; BETA THALASSEMIA; CELL FUNCTION; CHELATION THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GLUCOSE METABOLISM; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LETTER; MALE; MONOTHERAPY; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; BETA-THALASSEMIA; BLOOD GLUCOSE; CHELATION THERAPY; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IRON CHELATING AGENTS; MALE; RETROSPECTIVE STUDIES;

EID: 33748742706     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2006.06296.x     Document Type: Letter

References (6)

1. Daar, S. & Pathare, A.V. (2006) Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload. Annals of Hematology, 85, 315-319.
2. Farmaki, K., Angelopoulos, N., Anagnostopoulos, G., Gotsis, E., Rombopoulos, G. & Tolis, G. (2006) Effect of enhanced iron chelation therapy on glucose metabolism in patients with beta-thalassaemia major. British Journal of Haematology, 134, 438-444.
3. Gamberini, M.R., Fortini, M., Gilli, G., Testa, M.R. & De Sanctis, V. (1998) Epidemiology and chelation therapy effects on glucose homeostasis in thalassaemic patients. Journal of Pediatric Endocrinology and Metabolism, 11(Suppl. 3), 867-869.
4. Giardina, P.J. & Grady, R.W. (2001) Chelation therapy in beta-thalassemia: an optimistic update. Seminars in Hematology, 38, 360-366.
5. Gutt, M., Davis, C.L., Spitzer, S.B., Llabre, M.M., Kumar, M., Czarnecki, E.M., Schneiderman, N., Skyler, J.S. & Marks, J.B. (2000) Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures. Diabetes Research and Clinical Practice, 47, 177-184.
6. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F. & Turner, R.C. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419.